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Figure S1. Characterization of O-GlcNAcylated ubiquitin. O-GlcNAcylated ubiquitin was purified by 
RP-HPLC and characterized by ESI-MS.
Figure S2. Final protein precipitation improves the detection of mass-tagging. Cell lysates were 
enzymatically modified by GalNAz and then reacted with DBCO-PEG. The resulting reactions were then 
terminated by either boiling in SDS-PAGE loading buffer (Null) or by methanol/chloroform/H2O 
(Precip). The precipitated proteins were then resuspended, and Nup62 and CREB were visualized by 
Western blotting.
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Figure S3. Several antibodies recognize bacterial proteins in recombinant GalT preparations. 
GalT(Y289L) was recombinantly expressed in E. coli and purified in four independent experiments. 
These different recombinant preparations (1-4) of GalT(Y289L) were individually subjected to SDS-PAG 
and Western blotting with the indicated antibodies against various proteins or commonly used affinity 
tags. The purity of the GalT(Y289L) preps was visualized by Ponceau S staining.
Figure S4. An O-GlcNAc-deficient mutant of CREB is not mass-shifted.	H1299 cells were transiently 
transfected with either FLAG-tagged wild-type CREB or a multiple mutant (S40, T227, T228, T259, 
S260, T261 to A) that is not O-GlcNAcylated. The corresponding cell lysates were enzymatically 
modified by GalNAz and then reacted with DBCO-PEG before visualization by Western blotting.
Figure S5. DMSO concentration is not a major driver of SPAAC efficiency. (A) O-GlcNAcylated 
ubiquitin was added to cell lysates before enzymatic modification with GalNAz and reaction with the 
indicated concentrations of DBCO-PEG (10% final volume of DMSO) for 16 h at room temperature and 
analysis by Western blotting. (B) The mass-shifting reactions were performed as in (A) but with SPAAC 
at 98 °C for 5 min.
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Experimental Methods
General 
Unless otherwise indicated, all solvents and reagents were purchased from commercial sources 
(Sigma-Aldrich, Fluka, MilliporeSigma, Novagen, etc.) and used without any further purification. 
Iodoacetamide was purchased from VWR, TCEP (tris(2-carboxyethyl)phosphine) was purchased from 
ThermoFisher Scientific,  the Click-iT O-GlcNAc Enzymatic Labeling System (C33368) was purchased 
from ThermoFisher Scientific. Alkyne-PEG5000, DBCO-PEG5000, and THPTA 
(tris-hydroxypropyltriazolylmethylamine),  were purchased from Click Chemistry Tools, 
Aminooxy-PEG5000 was purchased from Nanocs Inc. UDP-2-keto-galactose was synthesized following 
published procedures.1 UDP-GalNAz was also synthesized in house following published procedures.2 All 
aqueous solutions were prepared using ultrapure laboratory grade water (deionized, filtered, sterilized) 
obtained from an in-house ELGA water purification system and filter sterilized with 0.45 μm syringe 
filters (VWR) before use. Growth media (LB broth, Miller, Novagen and TB broth, Sigma) were 
prepared, sterilized, stored, and used according to the manufacturer. Antibiotics were prepared as stock 
solutions at a working concentration of 1000 X (ampicillin sodium salt, MilliporeSigma 100 mg mL-1; 
kanamycin sulfate, MilliporeSigma, 50 mg mL-1) and stored at -20 °C. All bacterial growth media and 
cultures were handled using sterile conditions under open flame. All silica gel column chromatography 
was performed using 60 Å silica gel (MilliporeSigma) and all thin-layer chromatography performed using 
60 Å, F254 silica gel plates (MilliporeSigma) with detection by ceric ammonium molybdate (CAM) 
and/or UV light. Reversed phase high-performance liquid chromatography (RP-HPLC) was performed 
using an Agilent Technologies 1200 Series HPLC with Diode Array Detector. Unless otherwise stated the 
HPLC buffers used were buffer A: 0.1% trifluoroacetic acid (TFA) in H2O, buffer B: 0.1% TFA, 90% 
acetonitrile  in H2O. Mass spectra were acquired on an API 3000 LC/MS-MS System (Applied 
Biosystems/MDS SCIEX).
Peptide Synthesis
Solid-phase peptide syntheses were conducted manually on unprotected Rink amide ChemMatrix resin 
(PCAS BioMatrix) with an estimated loading of 0.6 mmol g-1. Protected O-GlcNAcylated serine was 
prepared as previously described.3 Commercially available N-Fmoc and side-chain-protected amino acids 
(5 equiv, Anaspec) were activated for 20 min with HBTU (5 equiv, Novabiochem) and 
N,N-diisopropylethylamine (DIEA) (10 equiv, Sigma) and then coupled to the resin for 1.25 h followed 
by 4 x 1 min DMF washes. After coupling, the terminal Fmoc group was removed with 2 x 20% v/v 
piperidine in DMF for 20 min and then followed by 4 x 1 min DMF washes. For activated glycosylated 
amino acids, 2 equivalents of the pentafluorophenyl activated-ester in DMF was coupled overnight. When 
peptides were completed, the final Fmoc group was removed as described above, and the N-terminal 
amine was acetylated with 5 equivalents each of pyridine and acetic anhydride in DMF and then washed 3 
x DMF. The acetyl groups on glycosylated amino acids were deprotected with 2 x MeOH for 1 min 
followed by 3 x 20% hydrazine monohydrate in MeOH twice for 30 min. The peptide was then cleaved 
from the resin by incubating in cleavage cocktail (95:2.5:2.5 TFA/H2O/triisopropylsilane) for 3.5 h at 
room temperature. The peptides were then diluted approximately 1/10 in cold diethyl ether and 
precipitated overnight (-80 °C). The resulting suspensions were centrifuged (30 min, 5,000 x g, 4 °C). The 
pellet was then resuspended in H2O, flash frozen, and lyophilized. Crude lyophilized material was purified 
using an 8% to 17.5% B gradient over 16 min. Calculated = 1179.64, observed = 1179.04.  Yield, 10.2 
mg.
Cloning of pTXB1-HA-Ubiquitin-AvaDnaE-6XHis
The plasmid was prepared by following standard molecular cloning techniques. 
pTXB1-Ubiquitin-AvaDnaE-6XHis was generated as previously described.4,5 HA-Ubiquitin insert was 
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generated by cloning ubiquitin to include 5’ NdeI digestion site followed by a HA tag, and a ‘3 Bpu10I 
digestion site from pTXB1-Ubiquitin-AvaDnaE-6XHis. The resulting PCR product was cloned into the 
pTXB1-Ubiquitin-AvaDnaE-6XHis vector between the Ndel and Bpu10I sites. Plasmid is available upon 
request.
HA-Ubiquitin-MESNa Expression and Purification.  
pTXB1-HA-Ubiquitin-AvaDnaE-6XHis was subsequently transformed into BL21 E. coli (Novagen). 
Terrific broth (4 x 300 mL) containing ampicillin (100 μg mL-1) was inoculated with 3 mL of starter 
culture grown overnight at 37 °C. The 300-mL culture was grown at 37 °C until an OD (A600) of 0.60, at 
which time expression was induced with 0.5 mM isopropyl β-D-1-thiogalacto-pyranoside (IPTG) for 16 h 
at 25 °C. Cells were harvested by centrifugation (10 min, 6,000 x g, 4 °C). The pooled pellets were 
suspended in 40 mL  Buffer A (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8) and sonicated 
for 8 min (30 s on, 30 s off). The resulting lysate was then centrifuged for 1 h at 6,000 x g, 4 °C. The 
supernatant was transferred into a new tube and 2.5 mL of prewashed Ni-NTA Agarose (Qiagen) was 
added and placed onto a rotator for 1 h, 4 °C. The solution was then transferred to a gravity-flow column 
and allowed to drain, and washed with an addition 100 mL of Buffer A. HA-Ubiquitin-AvaDnaE-6XHis 
was eluted with Buffer B (Buffer A with 250 mM imizozole). Eluted fractions were dialyzed against 1 L 
dialysis buffer (100 mM NaH2PO4, 150 mM NaCl, 1 mM ethylenediaminetetraacetic acid (EDTA), and 1 
mM TCEP HCl, pH 7.75). To the dialyzed protein, an equal volume of sodium mercaptoethanesulfonate 
(MESNa) buffer (100mM NaH2PO4, 150 mM NaCl, 1 mM EDTA, 2 mM TCEP HCl, and 400 mM 
MESNa, pH 7.75) was added, and the mixture was incubated overnight to generate the protein thioester. 
Crude material was purified using a 30% to 60% B gradient over 20 min. Calculated = 9773 Da, observed 
= 9775 ± 2 Da. Yield, 10 mg L-1 of TB 
Expressed Protein Ligation.
To a tube containing 11 mg of HA-Ubiquitin-MESNa (1 eq) in 4.4 mL of ligation buffer (3 M guanidine 
HCl, 300 mM NaH2PO4, 30 mM MPAA, 30 mM TCEP, pH 7.5) was added 2.8 mg of the O-GlcNAc 
Peptide (2 eq). The reaction was covered in foil and left on a rocker for 24 h. Crude material was purified 
by 38% to 42% B gradient over 15 min. Calculated = 10,810 Da, observed = 10,813 ± 1 Da. Yield, 5.1 
mg.
Antibodies
Anti-HA-Tag (3724S) was purchased from Cell Signaling Technology, and the blocking solution was 5% 
BSA in Cell Signaling Technology TBST. Anti-CREB1 (9104S) was purchased from Cell Signaling 
Technology, and the blocking solution was 5% non-fat milk in Cell Signaling Technology TBST. 
Anti-Nup62 (610497) was purchased from BD Biosciences, and the blocking solution was 5% non-fat 
milk in ThermoFisher Scientific TBST. Anti-FLAG-Tag (2368S) and Anti-TDP43 (3448S) were 
purchased from Cell Signaling Technology, and the blocking solution was 5% BSA in Cell Signaling 
Technology TBST. Anti-caspase-6 (9104S) was purchased from Cell Signaling Technology, and the 
blocking solution was 5% non-fat milk in Cell Signaling Technology TBST. Anti-OGA was purchased 
from Sigma Aldrich, and the blocking solution was 5% non-fat milk in ThermoFisher Scientific TBST. 
Anti-NEDD4 (07-049) was purchased from MilliporeSigma, and the blocking solution was 5% non-fat 
milk in ThermoFisher Scientific TBST. Horseradish peroxidase (HRP)-conjugated secondary antibody 
was purchased from Jackson ImmunoResearch and incubated in the same TBST as primary antibodies. 
General Procedure for Western Blotting 
After proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE, 
Criterion TGX 4-20% Gel, Bio-Rad), proteins were transferred to a PVDF membrane (Bio-Rad) using 
manufacturer’s protocols on a Trans-Blot SD Semi-Dry Transfer Cell. All Western blots were blocked for 
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1 h at room temperature in appropriate blocking buffer. The blots were then incubated with the primary 
antibody in appropriate blocking buffer overnight at 4 °C. All primary antibodies were used at 1:1,000. 
The blots were then washed three times in TBST for 10 min and incubated with the horseradish 
peroxidase (HRP)-conjugated secondary antibody for 1 h in appropriate blocking buffer at room 
temperature. HRP-conjugated secondary antibodies were used at 1:10,000 dilutions. After being washed 
three more times with TBST for 10 min, the blots were developed using ECL reagents (Bio-Rad) and the 
ChemiDoc XRS+ molecular imager (Bio-Rad).
Cell Culture
H1299 were grown in RPMI media (Corning) supplement with 10% Fetal Bovine Serum (Altanta 
Biologicals). Cells were grown at 37 °C and 5.0% CO2.
Expression and Purification of GalT(Y289L) 
pET23a GalT(Y289L) plasmid, provided by P. Qasba, National Cancer Institute, was transformed into 
BL21 E. coli (Novagen). Terrific broth (300 mL) containing ampicillin (100 μg mL-1) was inoculated with 
2.5 mL of starter culture grown overnight at 37 °C. The 300-mL culture was grown at 37 °C until an OD 
(A600) of 0.70, at which time expression was induced with 1 mM IPTG for 4 h at 37 °C. Cells were 
harvested by centrifugation (10 min, 6,000 x g, 4 °C) and resuspended in 10 mL of suspension buffer 
(25% sucrose w/v in 1 x DPBS). Cells were lysed using sonication (30 s pulse, 30 s rest, 12 min at 4 °C). 
The resulting lysate was diluted to 80 mL in cold suspension buffer, and inclusion bodies were harvested 
by centrifugation (30 min, 15,000 x g, 4 °C) and washed 8 times by resuspension in 80 mL of suspension 
buffer followed by centrifugation. Inclusion bodies were then washed once with 80 mL of 10 mM 
phosphate (pH 7.0) and harvested by centrifugation. Inclusion bodies were then resuspended in 14 mL of 
cold H2O, poured over a mixture of 12 g solid guanidine HCl (GuHCl) and 944 mg Na2SO3, resulting in a 
final concentration of 5 M GuHCl and 300 mM Na2SO3, and then vortexed vigorously before adjusting 
the volume to 24 mL with cold H2O. Freshly made NTSB solution (50 mM 
(5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB), 1 M Na2SO3 in water pH 7.5) was then added with 
vigorous vortexing to sulfonate free thiols. Completion of the reaction is indicated by a color change from 
dark orange to pale yellow. Protein was then precipitated with cold H2O (250 mL) and centrifuged 
immediately (30 min, 15,000 x g, 4 °C). The protein pellet was washed three times by resuspension in 250 
mL cold H2O and centrifugation. The protein pellet was finally resuspended in 14 mL of cold H2O, poured 
over 12 g solid GuHCl, vortexed, and then diluted to 25 mL with H2O (resulting in a 5 M final 
concentration). The protein solution was diluted to a final concentration of 1 mg mL-1 with 5 M GuHCl 
solution (OD (A275) ≈ 2.0). This solution was diluted 10-fold into cold refolding buffer (5 mM EDTA, 4 
mM cysteamine, 2 mM cystamine, 100 mM Tris base, pH 8.0) with gentle stirring. Protein was allowed to 
refold for 48 h at 4 °C without agitation. The still refolding protein was then dialyzed two times into cold 
H2O for 24 h and concentrated using stirred cells (Amicon, MilliporeSigma) and centrifugal filters 
(10-kDa cutoff, Amicon Ultra, MilliporeSigma) to 3 mL. Buffer was exchanged once with 10 mL of 
reaction buffer (10 mM Tris base, pH 8.0), and final protein concentration was determined (OD (A275) ≈ 
2). Purified protein was stored at 4 °C. 
UDP-GalNAz Enzymatic Labeling for Strain-Promoted Azide-Alkyne Cycloaddition (SPAAC)
H1299 cells grown to 80% confluency in a 10-cm dish were collected by trypsinization and washed two 
times with PBS (2 min, 2,000 x g, 4 °C). The resulting cell-pellets were resuspended in 26 μL H2O 
containing 10X of c0mplete mini protease inhibitor cocktail (Sigma Aldrich), and 50 μL of 0.05% SDS 
buffer (0.05% SDS, 10 mM TEA pH 7.4, 150 mM NaCl) was added. To this, 1 μL benzonase 
(MilliporeSigma) was added, and the cells were incubated on ice for 30 min. Then, 200 μL of 4% SDS 
buffer (4% SDS, 10 mM TEA pH 7.4, 150 mM NaCl) was added, and the cells were briefly sonicated 
followed by centrifugation (10,000 x g for 10 min at 15 °C). Soluble protein concentration was 
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normalized by BCA assay (Pierce, ThermoFisher Scientific) to 1 mg mL-1. Proteins were precipitated by 
adding 3 x volume of methanol, 0.75 x volume of chloroform, and 2 x volume of H2O followed by 
vortexing and centrifugation (5 min, 5,000 x g). The aqueous phase was discarded without disturbing the 
interface layer before adding a 2.5 x volume of methanol, vortexing, and pelleting the protein (10 min, 
5,000 x g). The resulting protein pellet was allowed to air dry for 5-10 min before being resuspended in a 
fourth of the original volume using 1% SDS GalT buffer (1% SDS, 20 mM HEPES, pH 7.9). Protein 
concentration was again normalized using the BCA Assay and diluted to 2.5 mg mL-1 in 1% SDS GalT 
buffer. To 40 μL of resuspended protein (100 μg) was added 49 μL of H2O, 80 μL of 2.5 X labeling buffer 
(5% IGEPAL CA-630, 125 mM NaCl, 50 mM HEPES, pH 7.9), 11 μL of MnCl2 (100 mM in H2O), and 
10 μL of UDP-GalNAz (0.5 mM in 10 mM HEPES, pH 7.9) and vortexed. Finally, 10 μL of purified 
GalT(Y289L) or H2O was added, and the reaction mixture was incubated for 20 h at 4 °C. 
UDP-GalNAz Enzymatic Labeling for Cu(I)-Catalyzed [3 + 2]  Azide−Alkyne Cycloaddition 
(CuAAC)
After protein lysis and precipitation which was described previously, soluble protein concentration was 
normalized by BCA assay to 2 mg mL-1. Dithiothreitol (DTT) was added (1 M stock, 25 mM final) and 
allowed to react at 60 °C for 45 min; afterwards, iodoacetamide (500 mM stock, 50 mM final) was added 
and allowed to react for 45 min in the dark. Unreacted DTT and iodoacetamide were then removed by 
methanol/chloroform/H2O precipitation as described previously, and pellets were washed 5 times with 
500 μL methanol. The resulting protein pellet was allowed to air dry for 5-10 min before being 
resuspended at 2.5 mg mL-1 using 1% SDS GalT buffer. To 40 μL of resuspended protein (100 μg) was 
added 49 μL of H2O, 80 μL of 2.5 X labeling buffer (5% IGEPAL CA-630, 125 mM NaCl, 50 mM 
HEPES, pH 7.9), 11 μL of MnCl2 (100 mM in H2O), and 10 μL of UDP-GalNAz (0.5 mM in 10 mM 
HEPES, pH 7.9) and vortexed. Finally, 10 μL of purified GalT Y289L or H2O was added, and the reaction 
mixture was incubated for 20 h at 4 °C.
ThermoFisher Scientific Enzymatic Labeling
Click-iT protein analysis was conducted as described by manufacture (ThermoFisher Scientific, Click-IT 
O-GlcNAc Enzymatic Labeling System). Sample preparation was conducted as above, but to 40 μL of 
resuspended protein (100 μg) was added 49 μL of H2O, 80 μL of labeling buffer, 11 μL of MnCl2, and 10 
μL of UDP-GalNAz and vortexed. Finally, 10 μL of GalT Y289L or H2O was added, and the reaction 
mixture was incubated for 20 h at 4 °C. 
UDP-2-keto-galactose Enzymatic Labeling
Sample preparation was conducted as above, but to 40 uL of resuspended protein (100 μg) was added 49 
μL of H2O, 80 μL of labeling buffer, 11 μL of MnCl2, and 10 μL of UDP-2-keto-galactose (10 mM in 10 
mM HEPES, pH 7.9) and vortexed. Finally, 10 μL of GalT Y289L or H2O was added, and the reaction 
mixture was incubated for 20 h at 4 °C. 
Alkylation of Cysteines and SPAAC 
After chemoenzymatic labeling as described previously, 7.5 μL of freshly made iodoacetamide (600 mM) 
in H2O was added directly for a final concentration of 22.6 mM, and the mixture was incubated for 30 
min in the dark. Unreacted UDP-GalNAz and iodoacetamide were then removed by 
methanol/chloroform/H2O precipitation as described previously. Air-dried protein pellets were 
resuspended in 90 μL 1% SDS (1% SDS, 150 mM NaCl, 50 mM TEA, pH 7.4). Then, 10 μL of 10 mM 
DBCO-PEG5000 in DMSO was added to a final concentration of 1 mM, and the mixture was incubated for 
16 h in the dark or for 5 min at 98 °C. Unless otherwise noted, unreacted DBCO-PEG5000 was then 
removed by precipitation as described previously. The pellet was allowed to air dry for 5-10 min, and then 
25 μL 4% SDS buffer was added to each sample. The mixture was sonicated in a bath sonicator to ensure 
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complete dissolution, and 25 μL of 2 x loading buffer (20% glycerol, 0.2% bromophenol blue, 1.4% β-
mercaptoethanol, pH 6.8) was then added. The samples were boiled for 5 min at 98 °C, and ~40 μg (or 
~18.75 μg) of protein was then loaded per lane for SDS-PAGE separation.
Cu(I)-Catalyzed [3 + 2] Azide−Alkyne Cycloaddition (CuAAC)
Chemoenzymatic labeling was conducted as described above, and CuAAC was performed as described 
previously.6 Unreacted UDP-GalNAz was then removed by precipitation as described. Air-dried protein 
pellets were resuspended in 50 μL 1% SDS-Tris (1% SDS, 50 mM Tris, pH 8) and 46 μL of H2O was 
added. In a separate tube, 2 μL of THPTA (500 mM THPTA in DMSO), 20 μL of CuSO4·5H2O (50 mM 
in H2O), and 400 μL of alkyne-PEG5000 (10 mM in 200 mM Na2HPO4 pH 8) were mixed (volumes 
indicated are for a total of 4 reactions). To each resuspended pellet, 100 μL of the above 
THPTA/CuSO4/PEG solution was added, and the solution was vortexed briefly before adding 4 μL of 
TCEP (100 mM in H2O). The reaction mixture was then vortexed gently and allowed to incubate for 24 h 
at 37 °C. Unreacted click reagents were removed by methanol/chloroform/H2O precipitation as described 
previously, and pellets were washed 5 times with 500 μL of MeOH. The pellets were allowed to air dry 
for 5-10 min, and 25 μL of 4% SDS buffer was added to each sample. The mixture was sonicated in a 
bath sonicator to ensure complete dissolution, and 25 μL of 2 x loading buffer was then added. The 
samples were boiled for 5 min at 98 °C, and 40 μg of protein was loaded per lane for SDS-PAGE.
Oxime Formation
After chemoenzymatic labeling, unreacted UDP-2-keto-galactose was removed by precipitation as 
described previously.1 Air-dried protein pellets were resuspended in 169.6 μL of 7 M urea in 10 mM 
HEPES, 2% CHAPS, 1 mM DTT, pH 7.9. Then 11.4 μL of 1.8 M sodium acetate (pH 3.89) was added 
followed by 24 μL of aminoxy-PEG5000 (60 mM in DMSO, Nanocs Inc.). 5 μL of the reaction was used to 
check the pH (pH-indicator strips pH 4.0 - 7.0, MilliporeSigma); the pH was further adjusted to 4.5 with 
1.8 M sodium acetate (pH 3.89) if necessary. The reaction was then incubated for 24 h at 25 °C before 
unreacted aminoxy-PEG5000 was removed by methanol/chloroform/H2O precipitation as described 
previously for CuAAC. The pellet was allowed to air dry for 5-10 min, and then 25 μL of 4% SDS buffer 
was added to each sample. The mixture was sonicated in a bath sonicator to ensure complete dissolution, 
and 25 μL of 2 x loading buffer was then added. The samples were boiled for 5 min at 98 °C, and 40 μg of 
protein was loaded per lane for SDS-PAGE. 
GalT(Y289L) Background Testing and Antibodies
2.5 μg of GalT(Y298L) (to mimic amount loaded for a Chemoenzymatic Labeling)  from four different 
batches of purified GalT(Y289L) was loaded into each well. Western blotting was performed as described 
above.
Transient CREB Transfection
H1299 cells were grown to 80% confluency and the media was exchanged with fresh media. The cells 
were transiently transfected with pLEMPRA-CREB-FLAG or pLEMPRA-CREB(6A)-FLAG plasmids7 
using Lipofectamine 2000 (ThermoFisher Scientific) according to the manufacturer’s protocol. 
Twenty-four hours post-transfection, cells were harvested and then sample preparation was conducted as 
above.
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